Novartis
Scope
Date
~
-
Bio & PharmaChong Kun Dang rallies on $1.3 bn deal with Novartis
Chong Kun Dang Pharmaceutical Corp.'s shares zoomed more than 25% on Monday on news that the South Korean medicine developer has signed its biggest-...
Nov 06, 2023 (Gmt+09:00)
-
Bio & PharmaNovartis $391 mn deal powers Samsung Biologics backlogs to record high
Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, inked a $391 million contract from Novartis, nearly fi...
Jul 10, 2023 (Gmt+09:00)
-
Bio & PharmaS.Korea's Alteogen signs $145 million tech export deal with Swiss company
South Korea's bio company Alteogen Inc. on Friday said it signed its fourth technology export contract since its 2018 development of the human recom...
Dec 30, 2022 (Gmt+09:00)
-
Bio & PharmaSamsung Biologics signs $81 mn CMO deal with Novartis
South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...
Jun 07, 2022 (Gmt+09:00)
language -
Korean brokerage firm to buy Novartis campus in Paris for $454 mn: report
Korea Investment & Securities Co. Ltd. is set to buy an office building of Swiss pharmaceutical company Novartis under construction in Paris for 5...
Sep 30, 2016 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand
